Quantification of Autonomic Nervous Activity During Hemodialysis
Primary Purpose
Chronic Kidney Disease on Hemodialysis
Status
Completed
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
Analysis of the holter electrocardiogram
Sponsored by

About this trial
This is an interventional treatment trial for Chronic Kidney Disease on Hemodialysis focused on measuring heart rate variability
Eligibility Criteria
Inclusion Criteria:
- Patients with stable undergoing hemodialysis without hanging in blood pressure during hemodialysis.
Exclusion Criteria:
- Patients with chronic atrial fibrillation
- Patients with frequent ventricular premature beats
- Patients with a permanent pacemaker
- Patients with taking antihypertensive drugs
- Patients with medical treatment due to changes in blood pressure
Sites / Locations
- Graduate School of Applied Informatics, University of Hyogo
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
measuring Holter electrocardiogram
Arm Description
Hotter ECG will be recorded continuously during hemodialysis
Outcomes
Primary Outcome Measures
The outcome measures was low frequency power (LF, ms2) to high frequency power (HF, ms2) ratio (LF/HF ratio) of heart rate variability. The three subject groups with difference ultrafiltration were compared by LF/HF ratio during hemodialysis session.
Variations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02754986
Brief Title
Quantification of Autonomic Nervous Activity During Hemodialysis
Official Title
Quantification of Autonomic Nervous Activity by Heart Rate Variability and Approximate Entropy in High Ultrafiltration Rate During Hemodialysis
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Hyogo
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study assesses autonomic nervous system function by power spectral analysis of RR interval dynamics in ultrafiltration subjects without blood pressure variation.
Detailed Description
Variations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability in hemodialysis patients without blood pressure variations during HD session.
The subjects will be divided into 3 groups, those with UFR < 10 ml/hr/kg; ≥10 ml/hr/kg but ≤ 15 ml/hr/kg; and >15 ml/hr/kg, and Holter ECG are recorded continuously during HD session using frequency analysis of RR intervals.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Disease on Hemodialysis
Keywords
heart rate variability
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
N/A
Enrollment
35 (Actual)
8. Arms, Groups, and Interventions
Arm Title
measuring Holter electrocardiogram
Arm Type
Experimental
Arm Description
Hotter ECG will be recorded continuously during hemodialysis
Intervention Type
Other
Intervention Name(s)
Analysis of the holter electrocardiogram
Other Intervention Name(s)
Analysis of heart rate variability with using holter electrocardiogram
Primary Outcome Measure Information:
Title
The outcome measures was low frequency power (LF, ms2) to high frequency power (HF, ms2) ratio (LF/HF ratio) of heart rate variability. The three subject groups with difference ultrafiltration were compared by LF/HF ratio during hemodialysis session.
Description
Variations over time in autonomic nervous activity due to differences in ultrafiltration rate will be evaluated by measuring heart rate variability.
Time Frame
4 hours
10. Eligibility
Sex
All
Maximum Age & Unit of Time
1 Year
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients with stable undergoing hemodialysis without hanging in blood pressure during hemodialysis.
Exclusion Criteria:
Patients with chronic atrial fibrillation
Patients with frequent ventricular premature beats
Patients with a permanent pacemaker
Patients with taking antihypertensive drugs
Patients with medical treatment due to changes in blood pressure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yuko Mizuno-Matsumoto, Ph.D.
Organizational Affiliation
Graduate School of Applied Informatics, University of Hyogo
Official's Role
Study Director
Facility Information:
Facility Name
Graduate School of Applied Informatics, University of Hyogo
City
Kobe
State/Province
Hyogo
ZIP/Postal Code
650-0047
Country
Japan
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Quantification of Autonomic Nervous Activity During Hemodialysis
We'll reach out to this number within 24 hrs